Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Thursday, February 26, 2015
Fourth Question of the Day February 26, 2015 How long should drugs or api be studied to determine whether they do what their sponsors say they do? Is a two month study long enough? A year? When do the rules below apply and when don't they? When should they? Do consumers care about this or is it just sufficient if a company does a study for a couple of months and makes the claim that a product works? Are we as consumers just to the point where we will try anything in hopes that it will help us? No? Maybe?
Third Question of the Day February 26, 2015 How many people are coming forward reporting scams similar to the one reported on CBS, especially people who did want the compounded pain, scar, and migraine medications? How many total number of patients have received the exact same formula of these compounded medications with no changes to the formula (ie not specifically tailored to the specific patient)? What if the numbers show that compounded pain creams are prescribed and billed more than commercially available pain medications? What is the solution then?
New report explores the intrathecal pumps market that is poised is to grow at a CAGR of 4.1% from 2014 to 2020, to reach an estimated value of USD 0.26 billion in 2020
http://www.whatech.com/market-research-reports/press-release/medical/44832-new-report-explores-the-intrathecal-pumps-market-that-is-poised-is-to-grow-at-a-cagr-of-4-1-from-2014-to-2020-to-reach-an-estimated-value-of-usd-0-26-billion-in-2020
Subscribe to:
Posts (Atom)